Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
Enrollment complete for cannabinoid MS study
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
The use of aminopyridines in neurological disorders.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
Laquinimod CHMP/EMA opinion
Very early MS -- insights from MRI.
The pill times 2: What every woman with multiple sclerosis should know.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Endocannabinoids and neurodegenerative diseases.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Multiple sclerosis.
Simvastatin in acute optic neuritis.
Pages
« first
‹ previous
…
145
146
147
148
149
150
151
152
153
…
next ›
last »